SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMERPRNewsWire • 10/16/21
OMEROS ALERT: Bragar Eagel & Squire, P.C. is Investigating Omeros Corporation on Behalf of Omeros Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 10/08/21
OMER EQUITY ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Omeros Corporation Investors with Losses to Inquire About Class Action Investigation - OMERPRNewsWire • 10/08/21
INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Omeros Corporation and Encourages Investors with Losses to Contact the FirmPRNewsWire • 10/07/21
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Omeros Corporation (OMER) on Behalf of InvestorsBusiness Wire • 10/06/21
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Omeros Corporation (OMER) on Behalf of InvestorsBusiness Wire • 10/05/21
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Omeros Corporation and Encourages Investors with Losses to Contact the FirmBusiness Wire • 10/05/21
INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Omeros Corporation and Encourages Investors With Losses to Contact the FirmBusiness Wire • 10/04/21
OMER INVESTOR ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Omeros Corporation Investors with Losses to Inquire About Class Action Investigation – OMERBusiness Wire • 10/04/21
Omeros Provides Regulatory Update on Biologics License Application for Narsoplimab in the Treatment of HSCT-TMABusiness Wire • 10/01/21
Omeros Corporation's (OMER) CEO Greg Demopulos on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/10/21
Omeros Corporation to Announce Second Quarter Financial Results on August 9, 2021Business Wire • 08/03/21
Omeros' Narsoplimab Associated With Improvement In Organ Function In Stem Cell Transplant PatientsBenzinga • 06/14/21
Omeros' Narsoplimab Pivotal Trial Data Shared in Oral Presentation at 2021 Annual Congress of the European Hematology AssociationBusiness Wire • 06/14/21